ImmunoShield Therapeutics is is to harnessing the life-saving potential of allogeneic cell therapies while eliminating the risks associated with chronic systemic immunosuppression. We achieve this through cutting-edge, high-throughput biomanufacturing technology and antigen-specific immune tolerance, making cell therapies and regenerative medicine accessible to all. We help others help patients, by revolutionizing the way we make medicine.
Company Details
- Employees
- 3
- Founded
- -
- Address
- Phoenix, Arizona, Us
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- HQ
- Phoenix, Arizona
Immunoshield Therapeutics Questions
Immunoshield Therapeutics's website is https://www.immunoshieldtherapeutics.com/
Immunoshield Therapeutics's LinkedIn profile is https://www.linkedin.com/company/immunoshield-therapeutics
Immunoshield Therapeutics has
3 employees.
View email and phone details for 3
employees at Immunoshield Therapeutics.
Immunoshield Therapeutics's industry is
Biotechnology Research
Immunoshield Therapeutics's top competitors are
Tessera Therapeutics,
Athena Stem Women,
Nuvalent, Inc.,
Hawk Biosystems,
Hyloris Pharmaceuticals,
Incog Biopharma Services,
Azurecell,
Lenoss Medical, Inc.,
Helix Biotech, Inc.,
Ibex Therapeutics.
Immunoshield Therapeutics's categories are Biotechnology Research
Immunoshield Therapeutics's founding year is 2021
